Article
Analysis of mutations in pncA reveals non-overlapping patterns among various lineages of Mycobacterium tuberculosis.
Scientific reports - 15 Mar 2018
Baddam Ramani, Kumar Narender, Wieler Lothar H, Lankapalli Aditya Kumar, Ahmed Niyaz, Peacock Sharon J, Semmler Torsten
Abstract excerpt
Pyrazinamide (PZA) is an important first-line anti-tuberculosis drug, resistance to which occurs primarily due to mutations in pncA (Rv2043c) that encodes the pyrazinamidase enzyme responsible for conversion of pro-drug PZA into its active form. Previous studies have reported numerous resistance-conferring mutations distributed across the entire length of pncA without any hotspot regions. As different lineages of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
